On Friday, April 9th, the New York Stock Exchange opened its doors to a plethora of investment choices and Macerich (NYSE:MAC) was among them. The stock opened at $10.10 – right in the middle of its 12-month low and high prices of $7.40 and $14.83 respectively.
Before we delve deeper into Macerich’s present-day financials, let’s take a look at its fifty-day simple moving average (SMA). Currently, it stands at $11.66 while its 200-day SMA is slightly lower at $11.33. Furthermore, the company has a debt-to-equity ratio of 1.54, implying that they have more liabilities than equity and that their assets may not be effectively utilized to generate money for investors in case of defaults.
Moreover, Macerich’s quick ratio is currently at 0.96 – indicating that they may have some difficulty paying off their short-term obligations with their current assets alone. Similarly, their current ratio stands at the same level as well – implying they could struggle with meeting their upcoming financial obligations if any arise.
Recently, Stocknews.com cut Macerich from a “hold” rating to a “sell” rating on April 1st; whereas Piper Sandler boosted its price objective on shares from $9 to $11 and gave it an “underweight” rating on February 8th this year; Goldman Sachs Group began coverage by issuing a “sell” rating alongside a target price of $8.50 back in March; finally Truist Financial upped Macerich’s price objective from $13 to $15 just last December.
As per Bloomberg’s data analysis, Macerich has an average rating of Hold on an average price target of $12.50 after six “sell” ratings alongside three “hold” ratings plus almost two “buy” recommendations.
Macerich also disclosed its latest dividend during which stockholders were issued $0.17 on a per-share basis paid on March 3, 2023. On February 17th, shares of MAC recorded record payments after the ex-dividend date was confirmed as February 16th this year.
To sum it up, there is more to Macerich’s current financial health than meets the eye with steep fluctuations in ratings from different investment firms and their dividends. It seems that shareholders must exercise due diligence before making any hasty decisions about investing their precious resources.
Analysis of Macerich’s Recent Earnings Estimates and Institutional Investment Trends
Macerich, a real estate investment trust (REIT) traded on the New York Stock Exchange under the symbol “MAC,” has recently been the subject of much discussion in the finance world. On April 5th, Zacks Research released a report to its clients and investors that lowered earnings per share (EPS) estimates for FY2024 from $1.80 to $1.78. Analyst N. Dass predicts that Macerich will produce an EPS of $1.78 for the year ending 2024, while consensus estimates remain at $1.80 per share.
But what’s behind this change in predictions? A number of hedge funds have either reduced or added to their stakes in Macerich over recent times, adding an element of uncertainty to financial projections related to this REIT moving forward. In terms of recent investments into Macerich, Belpointe Asset Management LLC acquired shares worth approximately $28,000 during Q4 of 2022 while Point72 Hong Kong Ltd invested around $29,000 during Q2 of 2022. Additionally, Northwestern Mutual Wealth Management Co., Wipfli Financial Advisors LLC, and Caption Management LLC all established positions in MAC near the end of last year.
However, it is worth noting that institutional investors own an impressive 80% majority stake in Macerich’s stock. Despite being publicly traded on NYSE since 1994 and experiencing market fluctuations over time like any other company would likely face when operating within its industry sector(s), Macerich remains a high-value investment proposition overall.
Moving forward into Q1 of 2025 and onward throughout FY2025, Zacks Research analysts estimate EPS rates around $.42 and roughly $1.82 respectively for MAC at those respective timeframes occurred above mentioned compound influencing factors prevail till then day-to-day price movement could be volatile with appropriate action implying rationality implemented carefully by traders interested in investing with Macerich.
Anytime uncertainty around stakeholder investments or projections into upcoming earnings periods present themselves, investors and traders should take care to do their due diligence before making any significant financial decisions that could impact their bottom line. For now, it seems as though analyst predictions remain steady for Macerich – but it’s important to keep a pulse on changes within the larger market and institutional investment world moving forward.
Source: beststocks.com
